Lacripep for the Treatment of Primary Sjögren–Associated Ocular Surface Disease: Results of the First-In-Human Study

The purpose of this study was to assess the safety, tolerability, dosing, and efficacy of the active 19 amino acid fragment of lacritin (Lacripep), a broad regulator of ocular surface homeostasis, in the treatment of ocular surface disease associated with primary Sjögren syndrome. METHODS: Two hundr...

Descripción completa

Detalles Bibliográficos
Autores principales: Tauber, Joseph, Laurie, Gordon W., Parsons, Edward C., Odrich, Marc G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cornea 2023
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895125/
https://www.ncbi.nlm.nih.gov/pubmed/35942530
http://dx.doi.org/10.1097/ICO.0000000000003091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895125/
https://www.ncbi.nlm.nih.gov/pubmed/35942530
http://dx.doi.org/10.1097/ICO.0000000000003091

Ejemplares similares